FDA Approves Synjardy XR (empagliflozin/metformin hydrochlor
The U.S. Food and Drug Administration (FDA) has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When used along with diet and exercise, Synjardy XR is indicated to improve blood sugar in adults with type 2 diabetes when both empagliflozin and metformin can be taken. It is marketed by Boehringer Ingelheim and Eli Lilly and Company.....

https://www.drugs.com/newdrugs/fda-approves-synjardy-xr-empagliflozin-metformin-hydrochloride-extended-release-adults-type-2-4465.html
Like
Comment
Share